To the full analysis
Equasens stock: growth
EQS.PAEquasens reported $263.17M in revenue for fiscal 2025, up 9.1% on the prior year, up 6.6% a year on average over up to five years.
Daily figure as of 12 Nov 2026
Revenue (Annual rate)
6.8%
per year from 2006 to 2025, per share 6.8%
Earnings (Annual rate)
9.3%
per year from 2006 to 2025, per share 9.5%
Free cash flow (Annual rate)
22.1%
per year from 2006 to 2025, per share 22%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 6.6% | 7.6% | 6.8% |
| Revenue per share | 6.7% | 7.7% | 6.8% |
| Earnings | 5.1% | 7.7% | 9.3% |
| Earnings per share | 6.0% | 8.1% | 9.5% |
| Free cash flow | 11.3% | 9.8% | 22.1% |
| Free cash flow per share | 11.4% | 9.9% | 22.0% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $74.95M | $8.13M | $1.19M |
| 2007 | $78.94M | $8.92M | $6.85M |
| 2008 | $83.23M | $9.89M | $0 |
| 2009 | $90.82M | $10.46M | $0 |
| 2010 | $101.87M | $11.93M | $11.54M |
| 2011 | $108M | $13.08M | $13.71M |
| 2012 | $120.97M | $15.04M | $17.28M |
| 2013 | $126.19M | $17.61M | $12.62M |
| 2014 | $127.47M | $18.93M | $17.7M |
| 2015 | $126.27M | $20.91M | $20.54M |
| 2016 | $142.85M | $22.88M | $18.45M |
| 2017 | $144.28M | $25.81M | $21.68M |
| 2018 | $165.21M | $28.3M | $19.66M |
| 2019 | $176.44M | $31.6M | $26.32M |
| 2020 | $191.11M | $34.18M | $30.64M |
| 2021 | $214.83M | $43.53M | $41.27M |
| 2022 | $238.2M | $51.46M | $52.02M |
| 2023 | $244.56M | $52.35M | $48.04M |
| 2024 | $241.18M | $40.31M | $39.96M |
| 2025 | $263.17M | $43.76M | $52.41M |
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 12 Jun 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.